These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2826307)

  • 1. Somatosensory-evoked potentials (SEPs) are affected differently by mu- and kappa-selective opioids in the dog.
    Freye E; Buhl R; Schenk GK
    Funct Neurol; 1987; 2(3):281-92. PubMed ID: 2826307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids with different affinity for subreceptors induce different effects on early and late sensory evoked potentials (SEP) in man.
    Freye E; Buhl R; Ciaramelli F
    NIDA Res Monogr; 1986; 75():551-4. PubMed ID: 2829001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bremazocine: an opiate that induces sedation and analgesia without respiratory depression.
    Freye E; Hartung E; Schenk GK
    Anesth Analg; 1983 May; 62(5):483-8. PubMed ID: 6301311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH
    Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Somatosensory evoked potentials under alfentanyl].
    Freye E; Segeth M; Hartung E
    Anaesthesist; 1984 Feb; 33(2):103-7. PubMed ID: 6143516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacodynamic effects of S-(+)-ketamine on EEG, evoked potentials and respiration. A study in the awake dog].
    Freye E; Latasch L; Schmidhammer H
    Anaesthesist; 1992 Sep; 41(9):527-33. PubMed ID: 1416007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
    Gerak LR; Butelman ER; Woods JH; France CP
    J Pharmacol Exp Ther; 1994 Nov; 271(2):993-9. PubMed ID: 7965822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The opioid tramadol demonstrates excitatory properties of non-opioid character--a preclinical study using alfentanil as a comparison].
    Freye E; Latasch L; Von Bredow G; Neruda B
    Schmerz; 1998 Feb; 12(1):19-24. PubMed ID: 12799988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction of S-(+)-ketamine with opiate receptors. Effects on EEG, evoked potentials and respiration in awake dogs].
    Freye E; Latasch L; Schmidhammer H; Portoghese P
    Anaesthesist; 1994 Nov; 43 Suppl 2():S52-8. PubMed ID: 7840415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML; Sadée W
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tifluadom, a benzodiazepine with opioid-like activity: study of its central mechanism of action in conscious dogs].
    Schaal M; Freye E; Windelschmidt R
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1986 Mar; 17(1):27-31. PubMed ID: 3084201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.
    Dykstra LA; Massie CA
    J Pharmacol Exp Ther; 1988 Sep; 246(3):813-21. PubMed ID: 2843630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tifluadom (KC 5103) induces suppression and latency changes on somatosensory evoked potentials which are reversed by opioid antagonists.
    Freye E; Hartung E; Schenk GK
    Life Sci; 1983; 33 Suppl 1():537-40. PubMed ID: 6319908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.